PILOT
831175
XINGANJIANG
873167
Beijing Highlander Digital Technology
300065
4
Hangzhou Gaoxin Materials Technology
300478
5
Shijihengtong Technology
301428
US Stock MarketDetailed Quotes
CRBU Caribou Biosciences
- 1.350
- +0.040+3.05%
Close Feb 14 16:00 ET
- 1.350
- 0.0000.00%
Post 20:01 ET
122.25MMarket Cap-0.81P/E (TTM)
1.420High1.320Low1.18MVolume1.350Open1.310Pre Close1.61MTurnover1.45%Turnover RatioLossP/E (Static)90.55MShares8.33052wk High0.43P/B110.11MFloat Cap1.22052wk Low--Dividend TTM81.56MShs Float32.645Historical High--Div YieldTTM7.60%Amplitude1.220Historical Low1.359Avg Price1Lot Size
About Caribou Biosciences Company
Caribou Biosciences, Inc. engages in the development of an internal pipeline of off-the-shelf CAR-T and CAR-NK cell therapies. Its tools and technologies provide transformative capabilities to basic and applied biological research, therapeutic development, agricultural biotechnology, and industrial biotechnology. The company was founded by Jennifer A. Doudna, Rachel E. Haurwitz, Martin Jinek and James Berger on October 28, 2011 and is headquartered in Berkeley, CA.
Company Profile
SymbolCRBU
Company NameCaribou Biosciences
Listing DateJul 23, 2021
Issue Price16.00
Founded2011
CEODr. Rachel Haurwitz, PhD
MarketNASDAQ
Employees158
Fiscal Year Ends12-31
Address2929 7th Street,Suite 105
CityBerkeley
ProvinceCalifornia
CountryUnited States of America
Zip Code94710
Phone1-510-982-6030
Websitehttp://www.cariboubio.com
Company Executives
- Name
- Position
- Salary
- Dr. Rachel Haurwitz, PhD
- President, Chief Executive Officer and Director
- 3.12M
- Barbara G. McClung, J.D.
- Chief Legal Officer and Corporate Secretary
- 1.22M
- Ruhi Ahmad Khan
- Chief Business Officer
- --
- Tim Kelly
- Chief Technology Officer
- --
- Sriram Ryali, M.B.A.
- Chief Financial Officer and Principal Accounting Officer
- --
- Dr. Steven B. Kanner, PhD
- Chief Scientific Officer
- 1.22M
- Ryan Fischesser
- Vice President, Finance and Controller
- --
- Andrew L. Guggenhime
- Chairman of the Board
- 202.74K
- Dr. Nancy C. Whiting, Pharm.D.
- Independent Director
- 140.62K
- Dr. Scott Braunstein, M.D.
- Independent Director
- 155.86K
- Ran Zheng
- Independent Director
- 157.20K
- Dr. Dara Richardson-Heron
- Independent Director
- 141.93K
- David L. Johnson, C.P.A.
- Independent Director
- 143.85K
- Dr. Natalie Sacks
- Independent Director
- 136.99K
Trending Stocks
Discussing
Big Tech’s earnings season in full swing! Nvidia is the only one left
On Thursday, $Amazon (AMZN.US)$ stock fell after the firm reported Q4 adjusted earnings of $1.86/share, vs estimates of $1.50/share, on reve
Moo Earnings
Feb 2 12:39
AMZN earnings preview: Grab rewards by guessing the opening price!